Literature DB >> 23252801

Fistula use after concurrent arteriovenous fistula formation and Tenckhoff catheter insertion.

Simon H Jiang1, Patrick G Lan, James Yeung, Martin Gallagher.   

Abstract

A significant proportion of peritoneal dialysis (PD) patients will have abrupt technique failure requiring conversion to haemodialysis, often using temporary vascular catheters as bridging access. However, vascular catheter use has been associated with increased mortality and great effort has been made to reduce their use. Just under two decades ago, a trial of dual arteriovenous fistula (AVF) formation and Tenckhoff catheter insertion reported only 4% of those in whom back-up fistulae were formed ever used them. Patient demographic, surgical technique and fistula care over those decades have changed substantially, potentially making this practice feasible. Thirty-five selected patients at Concord Repatriation and General Hospital had AVF formed at the time of Tenckhoff insertion and were entered prospectively into a vascular access database. We retrospectively examined this database with a median follow up of 345 days (interquartile range 183-658). Thirty-one per cent of all patients used the preformed AVF, and a further 19% who were still on PD had clinically functioning AVF. The vast majority (62%) had abrupt PD technique failure. This is a marked difference to dated reports of AVF use after concurrent PD and AVF formation. It raises the possibility that the formation of back-up fistula may be another method to reduce the need for vascular catheter use.
© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Year:  2013        PMID: 23252801     DOI: 10.1111/j.1440-1797.2012.01658.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  1 in total

1.  Machine Learning Improves Upon Clinicians' Prediction of End Stage Kidney Disease.

Authors:  Aaron Chuah; Giles Walters; Daniel Christiadi; Krishna Karpe; Alice Kennard; Richard Singer; Girish Talaulikar; Wenbo Ge; Hanna Suominen; T Daniel Andrews; Simon Jiang
Journal:  Front Med (Lausanne)       Date:  2022-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.